• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服硝酸盐和钙通道阻滞剂治疗未能预防5-氟尿嘧啶相关的心肌缺血:一例报告。

Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.

作者信息

Akpek G, Hartshorn K L

机构信息

Department of Medicine, Boston Medical Center, MA, USA.

出版信息

Cancer Chemother Pharmacol. 1999;43(2):157-61. doi: 10.1007/s002800050877.

DOI:10.1007/s002800050877
PMID:9923822
Abstract

BACKGROUND

Myocardial ischemia induced by 5-fluorouracil (5-FU) is a relatively rare, but potentially serious, occurrence. Some case reports have indicated that recurrent ischemia may be prevented if 5-FU is resumed after pretreatment with antianginal therapy.

METHODS

A 54-year old woman was diagnosed with stage IIA squamous cell carcinoma of the anus. Treatment with concurrent radiation and chemotherapy (mitomycin-C and 5-FU) was initiated with curative intent.

RESULTS

The patient had no evidence of underlying coronary artery disease based on history, physical examination or ECG. Approximately 48 h after initiation of 5-FU infusion the patient developed anginal pain associated with ECG changes compatible with ischemia. After resolution of ischemia and ruling out of myocardial infarction, coronary arteriography demonstrated normal coronary arteries. In an attempt to prevent myocardial ischemia, calcium channel blocker and nitrate therapy was started, but anginal pain with ECG change recurred when 5-FU was resumed. This necessitated selection of an alternative chemotherapy regimen.

CONCLUSIONS

Even in the presence of normal coronary arteries, antianginal therapy may not preclude the occurrence of potentially serious 5-FU induced myocardial ischemia. For patients who experience 5-FU-induced myocardial ischemia, development of alternative chemotherapy regimens should be considered.

摘要

背景

5-氟尿嘧啶(5-FU)诱导的心肌缺血是一种相对罕见但可能严重的情况。一些病例报告表明,如果在抗心绞痛治疗预处理后恢复使用5-FU,可预防复发性缺血。

方法

一名54岁女性被诊断为肛门IIA期鳞状细胞癌。开始采用同步放疗和化疗(丝裂霉素-C和5-FU)进行治疗,目的是治愈。

结果

根据病史、体格检查或心电图,该患者没有潜在冠状动脉疾病的证据。在开始输注5-FU约48小时后,患者出现与缺血性心电图改变相关的心绞痛。在缺血缓解并排除心肌梗死后,冠状动脉造影显示冠状动脉正常。为预防心肌缺血,开始使用钙通道阻滞剂和硝酸盐治疗,但恢复使用5-FU时,心绞痛伴心电图改变复发。这就需要选择替代化疗方案。

结论

即使冠状动脉正常,抗心绞痛治疗也可能无法预防潜在严重的5-FU诱导的心肌缺血。对于经历5-FU诱导心肌缺血的患者,应考虑制定替代化疗方案。

相似文献

1
Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.口服硝酸盐和钙通道阻滞剂治疗未能预防5-氟尿嘧啶相关的心肌缺血:一例报告。
Cancer Chemother Pharmacol. 1999;43(2):157-61. doi: 10.1007/s002800050877.
2
Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.恶性肿瘤患者接受不同剂量和给药方案的5-氟尿嘧啶治疗后的心脏毒性——427例患者的调查
Med Sci Monit. 2002 Jun;8(6):PI51-7.
3
A case of acute myocardial infarction during 5-fluorouracil infusion.一例在输注5-氟尿嘧啶期间发生急性心肌梗死的病例。
J Cardiovasc Med (Hagerstown). 2006 Nov;7(11):835-7. doi: 10.2459/01.JCM.0000250874.09273.9b.
4
Capecitabine-induced chest pain relieved by diltiazem.卡培他滨引起的胸痛用地尔硫䓬缓解。
Am J Cardiol. 2012 Dec 1;110(11):1623-6. doi: 10.1016/j.amjcard.2012.07.026. Epub 2012 Aug 31.
5
Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.5-氟尿嘧啶治疗期间持续性胸痛和ST段抬高患者的管理:两例报告
Ital Heart J. 2003 Dec;4(12):895-9.
6
Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk.化疗期间用 5-氟尿嘧啶引起的劳力性心肌缺血:被低估的风险。
Ann Oncol. 2014 May;25(5):1059-64. doi: 10.1093/annonc/mdu055. Epub 2014 Feb 20.
7
In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.体外实验证据表明,5-氟尿嘧啶化疗引起的心肌缺血是由于蛋白激酶C介导的血管平滑肌血管收缩所致。
Cancer Res. 1993 Jul 1;53(13):3028-33.
8
5-Fluorouracil cardiotoxicity: reversible left ventricular systolic dysfunction with early detection.5-氟尿嘧啶的心脏毒性:早期检测出的可逆性左心室收缩功能障碍
BMJ Case Rep. 2015 May 2;2015:bcr2015209347. doi: 10.1136/bcr-2015-209347.
9
Capecitabine induced cardiotoxicity: a case report and review of literature.卡培他滨诱导的心脏毒性:一例病例报告及文献综述
Pak J Pharm Sci. 2012 Jan;25(1):277-81.
10
Fluoropyrimidine-associated cardiotoxicity: revisited.氟嘧啶相关心脏毒性:再探讨
Expert Opin Drug Saf. 2009 Mar;8(2):191-202. doi: 10.1517/14740330902733961.

引用本文的文献

1
Mechanisms of Myocardial Ischemia in Cancer Patients: A State-of-the-Art Review of Obstructive Versus Non-Obstructive Causes.癌症患者心肌缺血的机制:阻塞性与非阻塞性病因的最新综述
Rev Cardiovasc Med. 2022 Jun 24;23(7):227. doi: 10.31083/j.rcm2307227. eCollection 2022 Jul.
2
The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.血管痉挛和微循环功能障碍在氟尿嘧啶诱导的缺血性心脏病中的作用
J Clin Med. 2022 Feb 25;11(5):1244. doi: 10.3390/jcm11051244.
3
Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment.
应对结直肠癌治疗中的5-氟尿嘧啶心脏毒性
Cancer Manag Res. 2022 Jan 23;14:273-285. doi: 10.2147/CMAR.S273544. eCollection 2022.
4
Delayed Coronary Vasospasm in a Patient with Metastatic Gastric Cancer Receiving FOLFOX Therapy.一名接受FOLFOX治疗的转移性胃癌患者发生延迟性冠状动脉痉挛
Fed Pract. 2021 May;38(Suppl 2):S76-S80. doi: 10.12788/fp.0123.
5
Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity.氟尿嘧啶诱导的心脏毒性的结直肠癌患者的替代治疗选择
Onco Targets Ther. 2020 Oct 9;13:10197-10206. doi: 10.2147/OTT.S264156. eCollection 2020.
6
5-FU induced cardiotoxicity: case series and review of the literature.5-氟尿嘧啶诱导的心脏毒性:病例系列及文献综述
Cardiooncology. 2019 Sep 6;5:13. doi: 10.1186/s40959-019-0048-3. eCollection 2019.
7
Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?远程缺血预处理在预防5-氟尿嘧啶诱导的冠状动脉痉挛中是否起作用?
Cond Med. 2019 Oct;2(5):204-212.
8
Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions.5-氟尿嘧啶诱导的冠状动脉痉挛:提出的机制、现有的管理方案及未来方向
Interv Cardiol. 2019 May 21;14(2):89-94. doi: 10.15420/icr.2019.12. eCollection 2019 May.
9
5-fluorouracil and cardiotoxicity: a review.5-氟尿嘧啶与心脏毒性:综述
Ther Adv Med Oncol. 2018 Jun 18;10:1758835918780140. doi: 10.1177/1758835918780140. eCollection 2018.